NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00075699,Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma,https://clinicaltrials.gov/study/NCT00075699,,COMPLETED,"RATIONALE: Active symptom control may decrease chest pain, breathlessness, sweating, and general discomfort in patients with malignant pleural mesothelioma. It is not yet known if active symptom control is more effective with or without chemotherapy.

PURPOSE: This randomized phase III trial is studying active symptom control and chemotherapy to see how well they work compared to active symptom control alone in treating patients with malignant pleural mesothelioma.",NO,Malignant Mesothelioma,DRUG: cisplatin|DRUG: mitomycin C|DRUG: vincristine sulfate|DRUG: vinorelbine tartrate|PROCEDURE: pain therapy|PROCEDURE: psychosocial assessment and care|PROCEDURE: quality-of-life assessment,Overall survival,"Palliation of chest pain, breathlessness, malaise (e.g., feeling weak, tiredness, anorexia), and sweating attacks|Performance status as measured by WHO grade|Analgesic usage|Toxicity as measured by the NCIC CTC|Quality of life as assessed by the European Organization for Research and Treatment of Cancer|Tumor response as measured by the RECIST criteria|Progression-free survival as measured by CT scan",,Medical Research Council,,ALL,"ADULT, OLDER_ADULT",PHASE3,840,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,BTS-MRC-MS01|CDR0000347461|ISRCTN54469112|EU-20349,2003-09,,,2004-01-13,,2013-08-07,"Leeds General Infirmary at Leeds Teaching Hospital NHS Trust, Leeds, England, LS1 3EX, United Kingdom|Saint Bartholomew's Hospital, London, England, EC1A 7BE, United Kingdom|Royal Marsden NHS Foundation Trust - Surrey, Sutton, England, SM2 5PT, United Kingdom",
